Skip to content
healthcare.dev

Divalproex sodium

NDC 0615-8377, Divalproex sodium, tablet, extended release, from NCS HealthCare of KY, LLC dba Vangard Labs.

Product NDC
0615-8377
Status
Listed
Labeler
NCS HealthCare of KY, LLC dba Vangard Labs
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209286
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8377 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIVALPROEX SODIUM500 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]

Package NDCNDC-11Package
0615-8377-390061583773930 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8377-39)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/319bbead-bec8-4bb7-9ecb-b2e161c44b8d

Use it

Look up 0615-8377 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8377 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0615-8377. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.